Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Stock Symbol
-
RAPP on Nasdaq
There are no Buy or Sell transactions made by ARCH Venture Partners XII, LLC since 4/23/2024
Holdings reported by ARCH Venture Partners XII, LLC for Rapport Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
3.73M |
$37.2M |
$9.98 |
Jun 10, 2024 |
By ARCH Venture Fund XII, L.P. |
|
|
| Series A Preferred Stock |
0 |
|
|
Jun 10, 2024 |
By ARCH Venture Fund XII, L.P. |
Common Stock |
|
| Series B Preferred Stock |
0 |
|
|
Jun 10, 2024 |
By ARCH Venture Fund XII, L.P. |
Common Stock |
|
Transactions reported by ARCH Venture Partners XII, LLC for Rapport Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.